These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34450104)

  • 1. Vaccine efficacy and iron deficiency: an intertwined pair?
    Drakesmith H; Pasricha SR; Cabantchik I; Hershko C; Weiss G; Girelli D; Stoffel N; Muckenthaler MU; Nemeth E; Camaschella C; Klenerman P; Zimmermann MB
    Lancet Haematol; 2021 Sep; 8(9):e666-e669. PubMed ID: 34450104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries.
    Solís Arce JS; Warren SS; Meriggi NF; Scacco A; McMurry N; Voors M; Syunyaev G; Malik AA; Aboutajdine S; Adeojo O; Anigo D; Armand A; Asad S; Atyera M; Augsburg B; Awasthi M; Ayesiga GE; Bancalari A; Björkman Nyqvist M; Borisova E; Bosancianu CM; Cabra García MR; Cheema A; Collins E; Cuccaro F; Farooqi AZ; Fatima T; Fracchia M; Galindo Soria ML; Guariso A; Hasanain A; Jaramillo S; Kallon S; Kamwesigye A; Kharel A; Kreps S; Levine M; Littman R; Malik M; Manirabaruta G; Mfura JLH; Momoh F; Mucauque A; Mussa I; Nsabimana JA; Obara I; Otálora MJ; Ouédraogo BW; Pare TB; Platas MR; Polanco L; Qureshi JA; Raheem M; Ramakrishna V; Rendrá I; Shah T; Shaked SE; Shapiro JN; Svensson J; Tariq A; Tchibozo AM; Tiwana HA; Trivedi B; Vernot C; Vicente PC; Weissinger LB; Zafar B; Zhang B; Karlan D; Callen M; Teachout M; Humphreys M; Mobarak AM; Omer SB
    Nat Med; 2021 Aug; 27(8):1385-1394. PubMed ID: 34272499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Iron Status on Adaptive Immunity and Vaccine Efficacy: A Review.
    Stoffel NU; Drakesmith H
    Adv Nutr; 2024 Jun; 15(6):100238. PubMed ID: 38729263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses.
    Tomalka JA; Suthar MS; Deeks SG; Sekaly RP
    Nat Immunol; 2022 Mar; 23(3):360-370. PubMed ID: 35210622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials.
    Lim HX; Arip M; Yahaya AAA; Jazayeri SD; Poppema S; Poh CL
    Front Biosci (Landmark Ed); 2021 Nov; 26(11):1286-1304. PubMed ID: 34856768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Considerations in boosting COVID-19 vaccine immune responses.
    Krause PR; Fleming TR; Peto R; Longini IM; Figueroa JP; Sterne JAC; Cravioto A; Rees H; Higgins JPT; Boutron I; Pan H; Gruber MF; Arora N; Kazi F; Gaspar R; Swaminathan S; Ryan MJ; Henao-Restrepo AM
    Lancet; 2021 Oct; 398(10308):1377-1380. PubMed ID: 34534516
    [No Abstract]   [Full Text] [Related]  

  • 8. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
    Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.
    Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y
    Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.
    Ura T; Yamashita A; Mizuki N; Okuda K; Shimada M
    Vaccine; 2021 Jan; 39(2):197-201. PubMed ID: 33279318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ongoing and future COVID-19 vaccine clinical trials: challenges and opportunities.
    Dal-Ré R; Bekker LG; Gluud C; Holm S; Jha V; Poland GA; Rosendaal FR; Schwarzer-Daum B; Sevene E; Tinto H; Voo TC; Sreeharan N
    Lancet Infect Dis; 2021 Nov; 21(11):e342-e347. PubMed ID: 34019801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid evolution of the COVID-19 pandemic calls for a unified public health response.
    He N
    Biosci Trends; 2021 Sep; 15(4):196-200. PubMed ID: 34193749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 vaccine challenges: What have we learned so far and what remains to be done?
    Forman R; Shah S; Jeurissen P; Jit M; Mossialos E
    Health Policy; 2021 May; 125(5):553-567. PubMed ID: 33820678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance - Eight U.S. Locations, December 2020-August 2021.
    Fowlkes A; Gaglani M; Groover K; Thiese MS; Tyner H; Ellingson K;
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1167-1169. PubMed ID: 34437521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Putative Role of Vitamin D for COVID-19 Vaccination.
    Chiu SK; Tsai KW; Wu CC; Zheng CM; Yang CH; Hu WC; Hou YC; Lu KC; Chao YC
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 vaccines: concerns beyond protective efficacy and safety.
    Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR
    Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 vaccines: ethical framework concerning human challenge studies.
    Calina D; Hartung T; Docea AO; Spandidos DA; Egorov AM; Shtilman MI; Carvalho F; Tsatsakis A
    Daru; 2020 Dec; 28(2):807-812. PubMed ID: 32851596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the Effectiveness of the Ad26.COV2.S Adenoviral Vector Vaccine for Preventing COVID-19.
    Corchado-Garcia J; Zemmour D; Hughes T; Bandi H; Cristea-Platon T; Lenehan P; Pawlowski C; Bade S; O'Horo JC; Gores GJ; Williams AW; Badley AD; Halamka J; Virk A; Swift MD; Wagner T; Soundararajan V
    JAMA Netw Open; 2021 Nov; 4(11):e2132540. PubMed ID: 34726743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.